Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
10.19
+0.20 (2.00%)
At close: Jul 8, 2025, 4:00 PM
10.00
-0.19 (-1.86%)
After-hours: Jul 8, 2025, 4:57 PM EDT

Anavex Life Sciences Ratios and Metrics

Millions USD. Fiscal year is Oct - Sep.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jul '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20 2015 - 2019
8704825378041,359274
Upgrade
Market Cap Growth
74.63%-10.27%-33.27%-40.83%396.34%64.61%
Upgrade
Enterprise Value
7453433826511,202246
Upgrade
Last Close Price
9.995.686.5510.3217.954.55
Upgrade
PB Ratio
8.554.013.785.659.0110.06
Upgrade
P/TBV Ratio
8.634.013.785.659.0110.06
Upgrade
Quick Ratio
6.708.8012.2714.9214.934.67
Upgrade
Current Ratio
6.748.8612.3214.9514.974.73
Upgrade
Return on Equity (ROE)
-40.17%-32.81%-33.41%-32.71%-42.58%-110.59%
Upgrade
Return on Assets (ROA)
-25.44%-21.81%-21.59%-18.95%-23.87%-55.77%
Upgrade
Return on Capital (ROIC)
-28.36%-24.12%-23.32%-20.31%-26.29%-70.26%
Upgrade
Earnings Yield
-5.48%-8.93%-8.85%-5.96%-2.79%-9.60%
Upgrade
FCF Yield
-3.46%-6.40%-5.18%-3.01%-2.23%-7.77%
Upgrade
Buyback Yield / Dilution
-3.60%-4.61%-3.74%-10.18%-19.95%-18.99%
Upgrade
Updated May 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q